Clinical Trial Update: A Prospective Randomized Phase III Study Comparing Hormonal Therapy +/-Docetaxel [Phase 3]

View source ↗

Summary

A prospective randomized Phase III trial comparing hormonal therapy with or without docetaxel for prostate cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Hormonal Therapy

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Adenocarcinoma of the Prostate | Phase 3 | Status: UNKNOWN